![MBM-17S Catalog No.:M23679-C 3-benzodiazol-2-yl)methyl]-9-(1-methyl-1H-pyrazol-4-yl)-2-(morpholin-4-yl)-9H-purin-6-amine](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M23679_1635915628.gif?v=1655715840)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
3-benzodiazol-2-yl)methyl]-9-(1-methyl-1H-pyrazol-4-yl)-2-(morpholin-4-yl)-9H-purin-6-amine
a process that is believed to play a pivotal role in 20-30% of all human tumors
It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site
550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection
InChiKey: CIRRFAQIWQFQSS-UHFFFAOYSA-N
MBM-17S Catalog No.:M23679-C 3-benzodiazol-2-yl)methyl]-9-(1-methyl-1H-pyrazol-4-yl)-2-(morpholin-4-yl)-9H-purin-6-amineMBM 17S is a potent NIMA related kinase 2 (Nek2) inhibitor, with an IC50 of 3 nM. MBM 17S effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM 17S shows antitumor activities, and no obvious toxicity to mice. Product information CAS Number: 2083621 91 2 Molecular Weight: 716. 74 Formula: C36H40N6O10 Chemical Name: 2 (benzyloxy) 4 (7 {1 [2 (dimethylamino)ethyl] 1H pyrazol 4 yl}imidazo[1,2 a]pyridin 3
US$ 625.00
US$ 445.00
US$ 155.78
US$ 139.99
US$ 800.00
US$ 286.50